Pfizer Hasn't Proved Rare-Disease Drug Works, FDA Staff Says
Staff at the U.S. Food and Drug Administration on Tuesday said Pfizer Inc. has failed to prove the effectiveness of nerve disorder treatment Vyndaqel and recommended against approving the drug, potentially...To view the full article, register now.
Already a subscriber? Click here to view full article